Pharmacogenomic Effects of Apolipoprotein E on Intracerebral Hemorrhage
Authors:
- 1 February 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 40 (2) , 632-639
Abstract
Background and Purpose— The purpose of the study was to evaluate the effect of APOE genotype and the feasibility of administering an apolipoprotein E-mimetic therapeutic to modify outcomes in a murine model of intracerebral hemorrhage. Methods— Intracerebral hemorrhage was induced via stereotactic injection of 0.1 U Clostridial collagenase into the left basal ganglia of wild-type and apolipoprotein-E targeted-replacement mice, consisting of either homozygous 3/3 or 4/4 genotypes. Animals were randomized to receive either vehicle or apolipoprotein E-mimetic peptide. Outcomes included functional neurological tests (21-point neuroseverity score and Rotorod latency) over the initial 7 days after injury, radiographic and histological hemorrhage size at 3 and 7 days, brain water content for cerebral edema at 24 hours, and quantitative polymerase chain reaction for inflammatory markers at 6, 24, and 48 hours. Results— Apolipoprotein-E targeted-replacement mice consisting of homozygous 3/3 demonstrated superior neuroseverity scores and Rotorod latencies over the first 3 days after intracerebral hemorrhage, decreased cerebral edema at 24 hours, and reduced upregulation of IL-6 and endothelial nitric oxide synthase at 6 hours when compared to their apolipoprotein-E targeted-replacement mice consisting of homozygous 4/4 counterparts. After intravenous administration of 1 mg/kg apolipoprotein E-mimetic peptide, both wild-type and apolipoprotein-E targeted-replacement mice consisting of homozygous 4/4 exhibited improved functional outcomes over 7 days after intracerebral hemorrhage, less edema at 24 hours, and reduced upregulation of IL-6 and endothelial nitric oxide synthase when compared to mice that did not receive the peptide. Conclusions— Our data indicate that APOE genotype influences neurological outcome after intracerebral hemorrhage in a murine model. In particular APOE4 is associated with poor functional outcome and increased cerebral edema. Additionally, this outcome can be modified by the addition of an apolipoprotein E mimetic-peptide, COG1410.Keywords
This publication has 32 references indexed in Scilit:
- Apolipoprotein E deficiency increased microglial activation/CCR3 expression and hippocampal damage in kainic acid exposed miceExperimental Neurology, 2006
- Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhageJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Brain edema after intracerebral hemorrhage in rats: The role of inflammationNeurology India, 2006
- Association of Apolipoprotein E4 and Haplotypes of the Apolipoprotein E Gene With Lobar Intracerebral HemorrhageStroke, 2005
- A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injuryExperimental Neurology, 2005
- Multiple pathways of apolipoprotein E signaling in primary neuronsJournal of Neurochemistry, 2005
- Hyperglycemia Exacerbates Brain Edema and Perihematomal Cell Death After Intracerebral HemorrhageStroke, 2003
- Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhageActa Neurologica Scandinavica, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Neurological Deficit and Extent of Neuronal Necrosis Attributable to Middle Cerebral Artery Occlusion in RatsStroke, 1995